ZR2 Bioenergy Ltd: Monitoring Agency Report on Preferential Issue Proceeds for Q2 FY27
REGULATORY
▼ Concern Flagged
MEDIUM RISK
📅 Filed on BSE: 14 Nov 2026, 08:31 PM IST · BSE ID: d7d2e00a-c396-4153-83b8-64d6be7a5836
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported on how it used money from a share sale, noting a concern about where Rs 18.50 crore is currently invested.
🤖 AI Summary
- ZR2 Bioenergy Ltd's Q2 FY27 Monitoring Agency Report on preferential issue proceeds filed.
- Rs 18.50 crore unutilized proceeds deployed with Sukhmehar Finance Private Limited.
- Deployment with non-deposit taking NBFC Sukhmehar Finance continues over 21 months.
- Board approved 12-month extension for Rs 18.50 crore deployment in May 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Unutilized Issue Proceeds Deployed
Rs 18.50 crore
Deployment Period with Sukhmehar Finance
Over 21 months (as of September 2026)
🏢 How This Affects the Company
The continued deployment of Rs 18.50 crore with Sukhmehar Finance Private Limited, a non-deposit taking NBFC, for an extended period raises questions about the availability of these funds for their original stated objects.
The report flags a deviation from industry practice and a lack of subsequent board approval for the continuation of the deployment, indicating potential operational and financial risks related to fund availability for planned projects.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders should monitor future disclosures regarding the utilization of these proceeds.
👤
Who Is Affected
All shareholders are affected as the report raises concerns about the potential implications for the future availability of Rs 18.50 crore for the stated objects of the preferential issue.
🔍
Management Signal
Management's signal indicates a continued reliance on a specific financial arrangement for unutilized funds, requiring closer scrutiny due to deviations from standard practices and extended deployment periods.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Next Monitoring Agency Report for Q3 FY27
Company disclosures on utilization of Rs 18.50 crore
Management updates on fund availability for stated objects
MEDIUM RISK
Concerns raised over deployment of preferential issue proceeds with a non-deposit taking NBFC.
💡 Investor Takeaway
ZR2 Bioenergy's Q2 FY27 Monitoring Agency Report flagged a qualification regarding the deployment of Rs 18.50 crore of unutilized preferential issue proceeds with Sukhmehar Finance Private Limited, a non-deposit taking NBFC, for over 21 months.
⚖️ Strengths & Concerns
⚠️ Concerns
- Rs 18.50 crore unutilized proceeds deployed with non-deposit taking NBFC for over 21 months.
- Lack of subsequent board resolution for continuation of Rs 18.50 crore deployment with Sukhmehar Finance Private Limited.
❓ Frequently Asked Questions
What is the ZR2 Bioenergy Ltd Monitoring Agency Report for Q2 FY27 about?
The report covers the utilization of proceeds from a preferential issue, with Crisil Ratings Limited acting as the monitoring agency for the quarter ended September 30, 2026.
What is the reported issue regarding the deployment of funds?
The company deployed Rs 18.50 crore of unutilized proceeds with Sukhmehar Finance Private Limited, a non-deposit taking NBFC, for over 21 months, which is a point of qualification in the report.
Has the deployment of Rs 18.50 crore been approved for continuation?
The Board approved an extension of 12 months from May 15, 2026, for the deployment of Rs 18.50 crore with Sukhmehar Finance Private Limited, however, no subsequent board resolution for continuation was provided.
What is the significance of Sukhmehar Finance Private Limited being a non-deposit taking NBFC?
Deploying unutilized proceeds with a non-deposit taking NBFC for an extended period, rather than low-risk liquid instruments, deviates from prevailing industry practice and may have implications for fund availability.
Questions based on this BSE filing only. For information purposes.